Content Details
S. 1224 (RS) - Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act
- Category
- Bills and Statutes
- Collection
- Congressional Bills
- SuDoc Class Number
- Y 1.6:
Y 1.4/1:
- Congress Number
- 116th Congress
- Congress Session
- 1st Session
- Last Action Date Listed
- June 28, 2019
- Actions
- Ms. Klobuchar (for herself and Mr. Grassley) introduced the following bill; which was read twice and referred to the Committee on the Judiciary, Reported by Mr. Graham, with an amendment and an amendment to the title
- Bill Number
- S. 1224
- Bill Version
- Reported in Senate (RS)
- Short Title
- Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act
- Full Title
- To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public heath concerns, and for other purposes.
- Sponsors
- Amy Klobuchar(MN)
- Cosponsors
- Chuck Grassley (IA)
- Committees
- Committee on the Judiciary (Standing)
- United States Code References
- 15 U.S.C. 12, 26, 45
and
53
21 U.S.C. 355 and 355
42 U.S.C. 262(k)
Loading...
Loading...